Skip to content
Screener

NRX Pharmaceuticals, Inc. NRXP Q4 2025 Annual earnings

Reported March 23, 2026 · Before market open

Revenue$983.0KMiss by $6.5M
EPS$0.19Beat by $0.28
Revenue estimate$7.5M
EPS estimate-$0.09

Next report

Nov 13, 2026 (in 2 months)
Revenue estimate$1.3M
EPS estimate-$0.26

FAQ

When did NRX Pharmaceuticals, Inc. report Q4 2025 earnings?
NRX Pharmaceuticals, Inc. (NRXP) reported Q4 2025 earnings on March 23, 2026 before market open.
What were NRX Pharmaceuticals, Inc.'s Q4 2025 revenue and EPS?
NRX Pharmaceuticals, Inc. reported revenue of $983.0K and eps of $0.19 for Q4 2025.
Did NRX Pharmaceuticals, Inc. beat estimates in Q4 2025?
Revenue missed the consensus estimate of $7.5M by $6.5M. EPS beat the consensus estimate of $-0.09 by $0.28.
How did NRX Pharmaceuticals, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 24475.0% from $4.0K a year earlier.
Where can I find NRX Pharmaceuticals, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001437749-26-009611) and the 10-K periodic report (0001437749-26-009418) directly on SEC EDGAR. The filing index links above go to sec.gov.